Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-12 Purchase |
2022-05-16 08:33 am |
Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director |
6,000 | $17.4 | $104,400 | 55,140 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-19 Option Award |
2024-06-20 6:05 pm |
N/A N/A |
TG THERAPEUTICS INC. | TGTX | Hoberman Kenneth Director |
22,250 | $0 | 264,935 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-13 4:22 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director |
30,000 | $0 | 103,140 (Direct) |
View |
| 2023-09-28 Option Award |
2023-09-29 5:01 pm |
N/A N/A |
TG THERAPEUTICS INC. | TGTX | Hoberman Kenneth Director |
20,000 | $0 | 242,685 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 08:15 am |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director |
18,000 | $0 | 73,140 (Direct) |
View |
| 2022-07-20 Option Award |
2022-07-22 4:31 pm |
N/A N/A |
TG THERAPEUTICS INC. | TGTX | Hoberman Kenneth Director |
43,732 | $0 | 222,685 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 4:47 pm |
2023-04-01 2032-04-01 |
Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2022-02-08 08:29 am |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director |
0 | $0 | 78,390 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 6:25 pm |
N/A N/A |
TG THERAPEUTICS INC. | TGTX | Hoberman Kenneth Director |
20,000 | $0 | 178,953 (Direct) |
View |
| 2020-06-22 Option Award |
2020-06-24 7:50 pm |
N/A N/A |
TG THERAPEUTICS INC. | TGTX | Hoberman Kenneth Director |
15,000 | $0 | 158,953 (Direct) |
View |
| 2020-06-10 Option Award |
2020-06-10 11:18 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer |
600,000 | $0 | 0 (Direct) |
View |
| 2020-06-10 Equity Swap |
2020-06-10 11:18 am |
N/A N/A |
STEMLINE THERAPEUTICS INC | STML | Hoberman Kenneth Chief Operating Officer |
1,374,352 | $0 | 0 (Direct) |
View |